News

36Kr Interview: N1 Life Opens New Path in R&D, Upgrades "Old Drugs" with Peptide Carrier

Academician Wender from Stanford, Co-founder of N1 Life, Unveils Latest RNA Delivery Vector for Tunable Liver-Targeted Delivery

Accuredit Therapeutics and N1 Life Form a Joint Venture Named 'Napoltec', Dedicated to the Development of Therapeutic Drug Delivery Systems and Pressing Ahead Clinical Translation

Dr. Zang Xiaoyu Was Interviewed by Suzhou TV to Share Her Entrepreneurial Journey

N1 Life Hosts Grand Opening for Suzhou Biobay Office

N1 Life Showcases Innovation at Bio China 2024 Expo

Paul Wender has been awarded the 2024 Biennial Sir Derek Barton Gold Medal by the Royal Society of Chemistry

PTAB Supports BioNTech and Pfizer in Initiating Patent Challenge against Moderna | Heavyweights Stand Their Ground, Patent Battle Over mRNA+LNP Technology Reviewed

Stanford spinout forms drug delivery joint venture with Chinese biotech

The key role of the protein corona: mRNA delivery system undergoes 'identity transformation' in the body, achieving organ targeting | Dr. Janice Zang presentation at BioCon.

Women Bloom With Grace, Please Listen to What They Have to Say.

Women-Led Life Sciences Companies in the Greater Bay Area Ranking List Revealed: N1 Life Was Selected

YDS Pharmatech Launches Data Partner Program with N1 Life, Leveraging Proprietary Peptide Experimental Data to co-develop Generative AI-driven peptide design platform